BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology
April 30, 2024 07:30 ET
|
BioRestorative Therapies, Inc
— Leading regenerative medicine and aesthetics innovators collaborate to build a vertically integrated, best-in-class biocosmeceutical platform — — Exclusive, five (5)-year agreement includes...
Hyloris élargit son Portefeuille avec un Nouveau Produit Candidat pour le Syndrome de la Bouche Brûlante
December 21, 2023 12:30 ET
|
Hyloris Pharmaceuticals SA
Hyloris élargit son Portefeuille avec un Nouveau Produit Candidat pour le Syndrome de la Bouche Brûlante Partenariat à parts égales avec AFT Pharmaceuticals pour le Développement d'un Nouveau Produit...
Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome
December 21, 2023 12:30 ET
|
Hyloris Pharmaceuticals SA
Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome Equal Partnership with AFT Pharmaceuticals for Development of a Novel Locally-Acting Product Candidate in Burning Mouth...
HydroGraph Signs Commercial Agreement with Leading Advanced Materials Supply Chain Firm
June 07, 2023 07:00 ET
|
Hydrograph Clean Power Inc.
VANCOUVER, British Columbia, June 07, 2023 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGCPF) (the “Company” or “HydroGraph”), a manufacturer of high-quality nanomaterials,...
Hyloris annonce un partenariat commercial pour Maxigesic® IV dans 9 pays européens
January 24, 2023 01:00 ET
|
Hyloris Pharmaceuticals SA
Signature d'un accord exclusif de licence et de distribution avec Salus Pharmaceuticals en Lituanie, Estonie, Lettonie, Croatie, Slovénie, Serbie, Macédoine du Nord, Monténégro et BosniePremiers...
Hyloris Announces Commercial Partnership for Maxigesic® IV in 9 European Countries
January 24, 2023 01:00 ET
|
Hyloris Pharmaceuticals SA
Exclusive licensing and distribution agreement signed with Salus Pharmaceuticals in Lithuania, Estonia, Latvia, Croatia, Slovenia, Serbia, North Macedonia, Montenegro and BosniaFirst commercial...
Nemaura Medical Announces Commercial Agreement with UK Licensee
September 27, 2021 08:00 ET
|
Nemaura Medical, Inc
Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up Loughborough, England, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura”...
MOBI724 signe un nouvel accord avec un partenaire commercial ayant des opérations dans plusieurs pays
March 15, 2019 08:53 ET
|
Solutions Globale Mobi724 inc.
MONTRÉAL, 15 mars 2019 (GLOBE NEWSWIRE) -- Solutions Globales MOBI724 inc. (« MOBI724 » ou la « Société ») (TSX-V:MOS, OTC QB:MOBIF), une société de technologie financière œuvrant à l’échelle...
MOBI724 Signs a New Commercial Agreement With a Business Partner With Operations in Multiple Countries
March 15, 2019 08:53 ET
|
Mobi724 Global Solutions Inc.
MONTREAL, March 15, 2019 (GLOBE NEWSWIRE) -- MOBI724 Global Solutions Inc. (“MOBI724” or the “Company”) (TSX-V: MOS) (OTCQB: MOBIF), a global Fintech company, offering a fully integrated suite of...
Mobi724 Signs a Commercial Agreement With Banco Promerica Guatemala
November 01, 2018 11:36 ET
|
Mobi724 Global Solutions Inc.
MONTREAL, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Mobi724 Global Solutions Inc. (“Mobi724” or the “Company”) (TSX-V:MOS) (OTCQB:MOBIF), a global Fintech company, offering a fully integrated suite of...